Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001057696 | SCV001222200 | pathogenic | Leber congenital amaurosis 13 | 2023-12-19 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 47 of the RDH12 protein (p.Ala47Thr). This variant is present in population databases (rs761231974, gnomAD 0.003%). This missense change has been observed in individual(s) with Leber congenital amaurosis and cone-rod dystrophy (PMID: 16269441, 17197551, 23105016, 26355662, 30134391). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 852972). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RDH12 protein function. Experimental studies have shown that this missense change affects RDH12 function (PMID: 16269441). For these reasons, this variant has been classified as Pathogenic. |
Ocular Genomics Institute, |
RCV001057696 | SCV001573404 | likely pathogenic | Leber congenital amaurosis 13 | 2021-04-08 | criteria provided, single submitter | research | The RDH12 c.139G>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PM3, PS3. Based on this evidence we have classified this variant as Likely Pathogenic. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001420746 | SCV001623089 | pathogenic | Leber congenital amaurosis | 2021-04-21 | criteria provided, single submitter | clinical testing | Variant summary: RDH12 c.139G>A (p.Ala47Thr) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251486 control chromosomes (gnomAD). c.139G>A has been reported in the literature in multiple individuals affected with Leber Congenital Amaurosis or retinal dystrophy or Retinitis pigmentosa & Rod cone dystrophy (Thompson_2005, Abu-Safieh_2013, Patel_2015). These data indicate that the variant is very likely to be associated with disease. In in vitro functional assays, the variant showed reduced ability to convert all-trans retinal to all-trans retinol exhibiting approximately 10% of wild-type activity (Thompson_2005). One ClinVar submitter (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Baylor Genetics | RCV001057696 | SCV004208591 | pathogenic | Leber congenital amaurosis 13 | 2023-07-25 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001057696 | SCV004801131 | pathogenic | Leber congenital amaurosis 13 | 2024-02-11 | criteria provided, single submitter | research | |
Natera, |
RCV001420746 | SCV002091251 | pathogenic | Leber congenital amaurosis | 2020-05-05 | no assertion criteria provided | clinical testing |